Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Triamcinolone and Bupivacaine Injection for Acute Bell's Palsy
NCT06955455Completed
- Sponsor
- Tishreen University Hospital
- Start
- Jan 2022
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of triamcinolone and bupivacaine in Bell's palsy, sponsored by Tishreen University Hospital. Primary endpoint: Improvement in facial nerve function using the House-Brackmann Facial Nerve Grading System at 3 months. Started Jan 2022; status: completed.
02
Drugs
triamcinolonebupivacaine
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT06955455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06955455.